Yixin Tang's 50 million yuan cash management product reached maturity, realizing proceeds of 368,200 yuan

Yixintang Pharmaceutical Group Co., Ltd. (Stock Code: 002727, referred to as “Yixintang”) announced today that the structured deposit product purchased with 50 million yuan of temporarily idle proprietary funds has matured and been recovered, realizing an investment income of 368,150.68 yuan.

The announcement shows that this investment is part of the company’s cash management plan approved at the 2024 annual shareholders’ meeting. On May 21, 2025, the Yixintang shareholders’ meeting approved the use of up to 2.5 billion yuan of idle proprietary funds for cash management, which can be rolled over within the approved limit. The investment scope includes fixed income or principal-protected floating yield financial products with a term of less than one year, large-denomination certificates of deposit, fixed deposits, etc.

The specific product that matured this time is “RMB Structured Deposit DWJCKM25060” issued by Huaxia Bank Co., Ltd. Kunming Hongta Branch, with a subscription amount of 50 million yuan. The product is principal-protected with a minimum return, starting interest on November 11, 2025, and maturing on March 16, 2026. The actual income earned was 368,200 yuan.

Looking back over the past 12 months, Yixintang has maintained active cash management, conducting multiple structured deposit investments. The main partner banks include Huaxia Bank, China Guangfa Bank, China CITIC Bank, Shanghai Pudong Development Bank, and China Construction Bank. Most investments are around 50 million yuan with a term of about 3 months. The following summarizes the company’s main cash management activities over the past year:

The announcement emphasizes that the company’s use of temporarily idle proprietary funds for cash management is carried out under the premise of ensuring daily operations and fund safety. It helps improve capital utilization efficiency and idle fund returns without affecting the normal development of the company’s main business. The company will continue to reasonably allocate idle funds within the 2.5 billion yuan limit in accordance with the shareholders’ authorization to achieve steady capital appreciation.

Click to view the original announcement >>

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. All information herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. If you have questions, contact biz@staff.sina.com.cn.